Literature DB >> 16781223

Use of B-type natriuretic peptide in the detection of myocardial ischemia.

Daniel Staub1, Charly Nusbaumer, Michael J Zellweger, Nils Jonas, Damian Wild, Matthias E Pfisterer, Jan Mueller-Brand, André P Perruchoud, Christian Mueller.   

Abstract

BACKGROUND: Exercise electrocardiography (ECG) has high specificity but limited sensitivity for the detection of myocardial ischemia. The aim of this study was to determine whether measurement of B-type natriuretic peptide (BNP) can improve the diagnostic accuracy of exercise ECG.
METHODS: A total of 256 consecutive patients with suspected myocardial ischemia referred for rest/ergometry myocardial perfusion single-photon emission computed tomography were enrolled. Levels of BNP were determined before and 1 minute after maximal exercise. RESULT: Inducible myocardial ischemia on perfusion images was detected in 127 patients (49.6%). Median BNP levels at rest and after peak exercise were higher in patients with than without inducible ischemia (71 pg/mL vs 38 pg/mL, P < .001; and 88 vs 52 pg/mL, P < .001, respectively). Compared with patients in the lowest peak exercise BNP quartile, those in the highest quartile of peak exercise BNP had more than 3 times the risk of inducible ischemia (adjusted relative risk 3.3, 95% CI 1.3-8.6, P = .015). Using 110 pg/mL as a cutoff, the combination of exercise ECG and peak exercise BNP level distinguished between ischemic and nonischemic patients more accurately than the exercise ECG alone (67% vs 60%, P = .024). Although the increase in accuracy was similar for the combination of exercise ECG with baseline BNP or DeltaBNP, overall, peak exercise BNP seemed to be the preferred measurement.
CONCLUSIONS: B-type natriuretic peptide levels are associated with inducible myocardial ischemia. The use of BNP levels improves the diagnostic accuracy of exercise ECG.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781223     DOI: 10.1016/j.ahj.2005.06.045

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  18 in total

1.  The never-ending story of cardiac biomarkers: A further step toward a very early detection of ischemic patients?

Authors:  Claudio Marcassa
Journal:  J Nucl Cardiol       Date:  2018-03-06       Impact factor: 5.952

2.  High BNP level as risk factor for acute kidney injury and predictor of all-cause mortality in STEMI patients.

Authors:  O Akgul; H Uyarel; H Pusuroglu; N Isiksacan; S Turen; M Erturk; O Surgit; O Celik; E Oner; A Birant; I F Akturk; N Uslu
Journal:  Herz       Date:  2014-06       Impact factor: 1.443

3.  Acute and chronic effects of exercise on inflammatory markers and B-type natriuretic peptide in patients with coronary artery disease.

Authors:  Juliano Lara Fernandes; Carlos Vicente Serrano; Flavia Toledo; Maria Fernanda Hunziker; Augusto Zamperini; Fabio H Teo; Romulo T Oliveira; Maria Heloisa Blotta; Maria Urbana Rondon; Carlos Eduardo Negrão
Journal:  Clin Res Cardiol       Date:  2010-09-12       Impact factor: 5.460

4.  B-type natriuretic peptide levels predict extent and severity of coronary artery disease in non-ST elevation acute coronary syndrome and normal left ventricular function.

Authors:  Brij Mohan Goyal; S M Sharma; Mohit Walia
Journal:  Indian Heart J       Date:  2013-12-26

5.  Additive Value of B-Type Natriuretic Peptide on Rest Tl-Dipyridamole Stress Tc-Sestamibi Gated Myocardial SPECT in Patients with Normal Left Ventricular Systolic Function.

Authors:  Jung-Ju Sir; Young-Seok Cho; Woo-Young Chung; Bon-Kwon Koo; In-Ho Chae; Dong-Ju Choi; Hyo-Soo Kim; Byung-Hee Oh; Young-Bae Park
Journal:  Cardiol Res Pract       Date:  2010-04-12       Impact factor: 1.866

6.  N-terminal pro-brain natriuretic peptide predicts myocardial ischemia and is related to postischemic left-ventricular dysfunction in patients with stable coronary artery disease.

Authors:  Gerald Vanzetto; Peggy Jacon; Alex Calizzano; Yannick Neuder; Patrice Faure; Daniel Fagret; Jacques Machecourt
Journal:  J Nucl Cardiol       Date:  2007-10-18       Impact factor: 5.952

7.  Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.

Authors:  Piercarlo Ballo; Irene Betti; Alessandro Barchielli; Daniela Balzi; Gabriele Castelli; Leonardo De Luca; Mihai Gheorghiade; Alfredo Zuppiroli
Journal:  Clin Res Cardiol       Date:  2015-11-07       Impact factor: 5.460

8.  Ischemia/reperfusion is an independent trigger for increasing myocardial content of mRNA B-type natriuretic peptide.

Authors:  Lafayete William F Ramos; Neif Murad; Eduardo Goto; Edinei L Antônio; José A Silva; Paulo F Tucci; Antônio C Carvalho
Journal:  Heart Vessels       Date:  2009-11-22       Impact factor: 2.037

9.  Combined Assessments of Biochemical Markers and ST-Segment Resolution Provide Additional Prognostic Information for Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Jong Shin Woo; Jin Man Cho; Soo Joong Kim; Myeong Kon Kim; Chong Jin Kim
Journal:  Korean Circ J       Date:  2011-07-30       Impact factor: 3.243

10.  Early diagnosis of rats with acute myocardial infarction by measurement of brain natriuretic peptide.

Authors:  Jian Li; Fang-Fang Yin; Ying-Long Hou
Journal:  Exp Ther Med       Date:  2013-02-18       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.